Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25871 | 222 | 30.4 | 68% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EXPT THER EUT PHARMACOINFORMAT | Address | 11 | 57% | 6% | 13 |
2 | PROSTACYCLIN SYNTHASE GENE | Author keyword | 9 | 83% | 2% | 5 |
3 | PROSTACYCLIN SYNTHASE | Author keyword | 7 | 32% | 8% | 18 |
4 | BIOTECHNOL MED BIOTECHNOL | Address | 3 | 57% | 2% | 4 |
5 | CYP5A1 | Author keyword | 3 | 100% | 1% | 3 |
6 | NAT PL SCI BIOL BOX 306 | Address | 2 | 67% | 1% | 2 |
7 | THROMBOXANE SYNTHASE | Author keyword | 2 | 14% | 6% | 13 |
8 | 12 S HYDROXYHEPTADECATRIENOIC ACID HHT | Author keyword | 1 | 100% | 1% | 2 |
9 | CYP8A1 | Author keyword | 1 | 50% | 1% | 2 |
10 | PROSTAGLANDIN 12 | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROSTAGLANDIN I 2 SYNTHASE | 9 | 59% | 5% | 10 |
2 | HELIX F G LOOP | 6 | 80% | 2% | 4 |
3 | THROMBOXANE SYNTHASE | 4 | 20% | 9% | 20 |
4 | 12 L HYDROXY 5 8 10 HEPTADECATRIENOIC ACID | 3 | 100% | 1% | 3 |
5 | PREDICTED 3 DIMENSIONAL STRUCTURE | 2 | 50% | 1% | 3 |
6 | TBXAS1 | 1 | 100% | 1% | 2 |
7 | THROMBOXANE SYNTHASES | 1 | 100% | 1% | 2 |
8 | HUMAN THROMBOXANE SYNTHASE | 1 | 33% | 1% | 2 |
9 | MEMBRANE ANCHOR DOMAIN | 1 | 50% | 0% | 1 |
10 | THROMBOXANE A2 SYNTHASE | 1 | 29% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Cellular and molecular biology of prostacyclin synthase | 2005 | 45 | 51 | 49% |
Advance in understanding the biosynthesis of prostacyclin and thromboxane A(2) in the endoplasmic reticulum membrane via the cyclooxygenase pathway | 2004 | 15 | 37 | 68% |
Genetic polymorphisms of prostacyclin synthase gene and cardiovascular disease | 2010 | 4 | 44 | 41% |
PROSTACYCLIN AND THROMBOXANE SYNTHASE - NEW ASPECTS OF HEMETHIOLATE CATALYSIS | 1994 | 51 | 37 | 41% |
GENOMIC ORGANIZATION AND REGULATION OF THE HUMAN THROMBOXANE SYNTHASE GENE | 1995 | 0 | 11 | 91% |
PREPARATION OF PROSTAGLANDIN-H2 - EXTENDED PURIFICATION ANALYSIS SCHEME | 1990 | 3 | 3 | 100% |
Prostacyclin Therapy for Pulmonary Arterial Hypertension | 2010 | 8 | 83 | 17% |
Role of endothelium in thrombosis and hemostasis | 1996 | 180 | 38 | 11% |
IMMUNO-QUANTITATION OF THROMBOXANE SYNTHASE IN HUMAN TISSUES | 1991 | 2 | 5 | 80% |
A CONCEPT FOR THE MECHANISM OF PROSTACYCLIN AND THROMBOXANE-A2 BIOSYNTHESIS | 1990 | 8 | 11 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPT THER EUT PHARMACOINFORMAT | 11 | 57% | 5.9% | 13 |
2 | BIOTECHNOL MED BIOTECHNOL | 3 | 57% | 1.8% | 4 |
3 | NAT PL SCI BIOL BOX 306 | 2 | 67% | 0.9% | 2 |
4 | RECEPTOR BIOLITABASHI KU | 1 | 25% | 1.4% | 3 |
5 | 438 MDR BLDG | 1 | 50% | 0.5% | 1 |
6 | BIOESTADISTICA EPIDEMIOL | 1 | 50% | 0.5% | 1 |
7 | HLTH SCI INTERNAL MED VASC BIOL | 1 | 50% | 0.5% | 1 |
8 | EA 2679 | 0 | 20% | 0.9% | 2 |
9 | MED VASC BIOL | 0 | 20% | 0.9% | 2 |
10 | HEMATOLVASC BIOL | 0 | 33% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000221732 | THROMBOXANE A2 RECEPTOR//THROMBOXANE RECEPTOR//THROMBOXANE A2 |
2 | 0.0000148132 | MPGES 1//PROSTAGLANDIN E SYNTHASE//MPGES 2 |
3 | 0.0000133878 | I EM NEURODEGENERAT BRAIN//BERAPROST SODIUM//NEONATE INFANT PATHOL |
4 | 0.0000125641 | PLASMA RECALCIFICATION//TAIL BLEEDING TIME//RAT PLATELET |
5 | 0.0000125484 | PROSTAGLANDIN H SYNTHASE//IMRECOXIB//AB HANCOCK JR MEM CANC |
6 | 0.0000120911 | PROSTACYCLIN STIMULATING FACTOR//CANINE PLATELET//CELLULAR METABOLITES |
7 | 0.0000106715 | 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE//PROSTAGLANDIN TRANSPORTER//15 PGDH |
8 | 0.0000106138 | ONO 1301//IP RECEPTOR//EP4 RECEPTOR |
9 | 0.0000087588 | 2 OXAZOLIDINONE DERIVATIVES//ALFUZOSIN HCL//DIGNOSIS |
10 | 0.0000085896 | CYCLOHEPTATRIENE NORCARADIENE EQUILIBRIUM//AZULENONE//BASE CATALYSED REARRANGEMENT |